D. Bhere

发表

Stem Cell Therapies: A Way to Promising Cures

K. Nawab, D. Bhere, Anthony Bommarito, 2019, Cureus.

Shattering barriers toward clinically meaningful MSC therapies

J. Karp, K. Shah, R. Abdi, 2020, Science Advances.

K. Shah, D. Bhere, 2015, Advances in cancer research.

Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells

Steven H. Liang, Y. S. Zhang, S. Smirnakis, 2022, Nature Communications.

Astrocyte elevated gene‐1 promotes hepatocarcinogenesis: Novel insights from a mouse model

N. Mukhopadhyay, P. Fisher, K. Shah, 2012, Hepatology.

Selective Cytotoxicity and Pro-apoptotic Activity of Stem Bark of Wrightia tinctoria (Roxb.) R. Br. in Cancerous Cells

K. Pai, D. Bhere, M. Setty, 2015, Pharmacognosy magazine.

A model of breast cancer meningeal metastases: characterization with in vivo molecular imaging

K. Shah, A. Brownell, C. Farrar, 2018, Cancer Gene Therapy.

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer

H. Wakimoto, Mohammad N. Alomary, D. Bhere, 2021, Cells.

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID‐19 related cytokine storm

H. Wakimoto, K. Shah, R. Ciccocioppo, 2021, Stem cells.

Evaluate to Antifungal Effect of Different Concentration of Organic Manure against the Alternaria Leaf Spot of Cabbage

D. Bhere, S. Simon, K. Solanke, 2020 .

AEG-1 regulates retinoid X receptor and inhibits retinoid signaling.

N. Mukhopadhyay, P. Fisher, K. Shah, 2014, Cancer research.

Decrowding Expansion Pathology: Unmasking Previously Invisible Nanostructures and Cells in Intact Human Brain Pathology Specimens

E. Boyden, K. Shah, Bobae An, 2021, bioRxiv.

Brain tumor cells in circulation are enriched for mesenchymal gene expression.

A. Iafrate, D. Louis, H. Wakimoto, 2014, Cancer discovery.

Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization

Z. H. Gümüş, Tunc Morova, D. Bhere, 2021, Oncogene.

Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies

K. Shah, D. Bhere, W. Hendriks, 2018, Stem cells.

TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia.

R. Young, A. Look, K. Stegmaier, 2017, Cancer discovery.

Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy

K. Shah, M. Matin, Yizheng Yao, 2020, Scientific Reports.

microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis

H. Wakimoto, K. Shah, B. Purow, 2018, Neuro-oncology.

Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas.

K. Shah, J. Lawler, K. Tamura, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma

J. Khan, C. Keller, K. Shah, 2017, Cell reports.

Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors

K. Shah, S. Lawler, Clemens Reinshagen, 2017, Scientific Reports.

CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors

H. Wakimoto, Wanlu Du, K. Shah, 2018, Science Translational Medicine.

Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors

K. Shah, U. Mahmood, P. Heidari, 2013, Stem cells.

Real-time multi-modality imaging of glioblastoma tumor resection and recurrence

K. Shah, Jose-Luiz Figueiredo, C. Farrar, 2012, Journal of Neuro-Oncology.

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors.

H. Wakimoto, R. Martuza, S. Rabkin, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases

U. Mahmood, A. Brownell, C. Farrar, 2023, Cancer Gene Therapy.

Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects

H. Wakimoto, K. Shah, R. Roovers, 2012, Proceedings of the National Academy of Sciences.

Imaging Migration and Fate of Stem Cells in Experimental Models of Cancer

K. Shah, D. Bhere, 2013 .

MicroRNA (miR)-124: A Promising Therapeutic Gateway for Oncology

D. Bhere, K. Sreedhara, K. Gourishetti, 2023, Biology.

TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia.

A. Look, K. Stegmaier, K. Shah, 2017, Cancer discovery.

A model of breast cancer meningeal metastases: characterization with in vivo molecular imaging

K. Shah, A. Brownell, C. Farrar, 2018, Cancer Gene Therapy.

Improved immunostaining of nanostructures and cells in human brain specimens through expansion-mediated protein decrowding

Yongxin Zhao, Jenna Aronson, D. Bhere, 2024, Science Translational Medicine.

Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas.

K. Shah, J. Lawler, Irina Nesterenko, 2024, Molecular therapy : the journal of the American Society of Gene Therapy.